Skip to main content

Drugstore chains reported mixed results for November on Tuesday, with

Walgreen

(WAG)

powering ahead of analysts' projections, while

CVS

(CVS) - Get CVS Health Corporation Report

came up short.

Total comparable-store sales at Walgreen rose 10.7%,

ahead of Wall Street's estimates, some of which ranged from positive 10.2% to 10.5%.

Comparable-pharmacy sales at the company rose 12.2% and prescriptions filled at comparable stores increased 5.9%. Front-end comparable-store sales were up 8.3% in the month, which beat Credit Suisse First Boston's estimate for a 6% increase.

The company said total sales were $2.92 billion, up 15.1% from a year ago, and total pharmacy sales were up 16.1%.

Calendar year-to-date sales were up 14% at $30.6 billion, while fiscal year-to-date sales were up 16.5% at $8.72 billion, Walgreen said.

The Deerfield, Ill.-based company closed one store and opened 57 new stores in November, which included 12 relocations. At Nov. 30, Walgreen had 4,291 drugstores, compared with 3,954 in the year-earlier period.

TheStreet Recommends

Meanwhile, Woonsocket, R.I.-based CVS reported a 5.3% increase in same-store sales in the four weeks ended Nov. 22, which was below Goldman Sachs' estimate for a 6.4% rise.

The company said pharmacy same-store sales were up 7.2% and front-end comp sales were up 1.3%. The numbers missed Goldman Sachs' estimates for a 8.5% increase in pharmacy same-store sales and Smith Barney Citigroup's projections for a 2% to 3% rise in front-end comps.

Total sales were $2.07 billion, up 7.4% from the previous year. Total pharmacy sales were 69.8% of total company sales in November.

Year-to-date, total sales were up 7.4% at $23.23 billion, compared with $21.63 billion in 2002. Same-store sales for the same period rose 5.3% over the prior year. Pharmacy same-store sales increased 7.7%, while front-end same-store sales were 0.5% higher.

"Our new store growth program is beginning to contribute meaningfully to our total sales growth," said CEO Tom Ryan in a press release. "In the front-end, we saw continued strength in our core categories, led by health and beauty aids."

On Nov. 22, CVS operated 4,167 retail and specialty pharmacy stores.

The remaining drugstore chains will report same-store sales later this week and early next week. On Dec. 4, Eckerd, which is owned by

J.C. Penney

(JCP) - Get J. C. Penney Company, Inc. Report

, will report its November comps, followed by

Rite Aid

(RAD) - Get Rite Aid Corporation Report

on Dec. 9.

Shares of Walgreen were recently off 4 cents, or 0.1%, at $37, while CVS shares were down 51 cents, or 1.4%, at $36.78.